Illumina Q3 earnings beat estimates, prompting Cwm LLC to boost its stake by 43.9%. Discover why analysts maintain a 'Hold' ...
Zacks Investment Research on MSN
Here's why Illumina (ILMN) is a strong momentum stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Learn more about whether Charles River Laboratories International, Inc. or Illumina, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics ...
Tempus AI’s TEM reimbursement showed modest sequential improvement in the third quarter of 2025, though average blended ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...
Illumina (ILMN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in ...
Why Illumina’s Latest Move Has Investors Watching Closely Illumina (ILMN) just deepened its bet on clinical whole genome sequencing by investing in and partnering with MyOme, backing a large Proactive ...
Illumina (NASDAQ:ILMN) supports global genomic science as nasdaq futures discussions include advanced life sciences platforms ...
In a report released today, from Jefferies maintained a Hold rating on Illumina, with a price target of $125.00. In addition to Jefferies, Illumina also received a Hold from J.P. Morgan’s Casey ...
In a report released today, Michael Ryskin from Bank of America Securities reiterated a Hold rating on Tempus AI, Inc. Class A, with a price target of $80.00.
Zacks Investment Research on MSN
Why Illumina (ILMN) is a top momentum stock for the long term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...
Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention. SAN DIEGO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results